Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $1.22 M | -76.09% |
2023 | $5.13 M | -92.06% |
2022 | $64.66 M | 6618.86% |
2021 | $0.96 M | 110.46% |
2020 | $0.45 M | -60.34% |
2019 | $1.15 M | -71.1% |
2018 | $3.98 M | 178.69% |
2017 | $1.43 M | 522.63% |
2016 | $0.22 M | -93.96% |
2015 | $3.8 M | -46.6% |
2014 | $7.12 M | 971.66% |
2013 | $0.66 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | $6.12 M | $33.76 M | ๐บ๐ธ USA |
Novavax NVAX | $37.88 M | $0.32 B | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $0.74 M | $3.75 M | ๐บ๐ธ USA |
NanoViricides NNVC | $0.06 M | $0.06 M | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | $0.12 M | $1.91 M | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.99 M | $6.57 M | ๐บ๐ธ USA |